NP001

· Neuraltus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NP001, covering 2010-10-06 to 2018-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation [Phase 2]

See pricing